# 278 ‒ Breast cancer: how to catch, treat, and survive breast cancer | Harold Burstein, M.D., Ph.D.

**Channel:** Peter Attia MD
**Upload Date:** 2023-11-06
**URL:** https://www.youtube.com/watch?v=IdKIF28C1xg
**Duration:** 137 minutes

## Description

Watch the full episode and view show notes here: https://bit.ly/3QnVz16
Become a member to receive exclusive content: https://peterattiamd.com/subscribe/
Sign up to receive Peter's email newsletter: https://peterattiamd.com/newsletter/

Harold (Hal) Burstein is an internationally renowned breast cancer expert. In this episode, Hal discusses a broad range of topics related to breast cancer, starting with the intricacies of breast anatomy and the endocrinological factors at play. He covers the spectrum of breast cancer, from precancerous lesions to invasive breast cancer, classifying these conditions into a helpful framework. He delves into various screening methods, including self-exams, mammograms, ultrasounds, and MRIs, and addresses the ongoing debate surrounding early screening and detection. Hal provides insights into the latest advancements in cancer treatment, offering valuable guidance for individuals to understand their unique circumstances within the three primary categories of breast cancer. Finally, Hal delves into the role of genetics in breast cancer and brings attention to the less commonly addressed issue of male breast cancer.

We discuss:
0:00:00 - Intro
0:00:52 - The prevalence and mortality rate of breast cancer in women
0:03:34 - The anatomy of the breast and the complex factors behind breast cancer development
0:15:00 - The three main categories of breast cancer
0:20:02 - Breast cancer risk: the impact of menopause, estrogen, breast density, obesity, and more
0:24:47 - Finding and evaluating lumps in the breast
0:31:12 - Identifying and treating precancerous lesions like ductal carcinoma in situ (DCIS)
0:42:41 - Post-lumpectomy for DCIS: standard of care, future risk of cancer, and pros and cons of radiation and other preventative options
0:57:43 - Lobular carcinoma in situ (LCIS): how it differs from DCIS in terms of treatment and future risk of invasive cancer
1:07:35 - Breast cancer screening: mammography, ultrasound, MRI, and more
1:15:36 - Invasive breast cancer: pathology report, surgery, and survival
1:28:04 - The argument for aggressive screening for breast cancer
1:33:30 - Advances in the treatment of breast cancer, adjuvant therapy, and neoadjuvant therapy
1:48:30 - The use of hormone replacement therapy in women who are in remission from breast cancer
1:52:32 - The role of genetics in breast cancer
2:01:53 - The importance of multidisciplinary care delivered by cancer centers
2:13:04 - Breast cancer in men
2:15:40 - Parting thoughts and takeaways

--------
About:

The Peter Attia Drive is a deep-dive podcast focusing on maximizing longevity, and all that goes into that from physical to cognitive to emotional health. With over 70 million episodes downloaded, it features topics including exercise, nutritional biochemistry, cardiovascular disease, Alzheimer’s disease, cancer, mental health, and much more.

Peter Attia is the founder of Early Medical, a medical practice that applies the principles of Medicine 3.0 to patients with the goal of lengthening their lifespan and simultaneously improving their healthspan. 

Learn more: https://peterattiamd.com

Connect with Peter on:
Facebook: http://bit.ly/PeterAttiaMDFB
Twitter: http://bit.ly/PeterAttiaMDTW
Instagram: http://bit.ly/PeterAttiaMDIG

Subscribe to The Drive:
Apple Podcast: http://bit.ly/TheDriveApplePodcasts
Overcast: http://bit.ly/TheDriveOvercast
Spotify: http://bit.ly/TheDriveSpotify
Google Podcasts: http://bit.ly/TheDriveGoogle

Disclaimer: This podcast is for general informational purposes only and does not constitute the practice of medicine, nursing, or other professional healthcare services, including the giving of medical advice. No doctor-patient relationship is formed. The use of this information and the materials linked to this podcast is at the user's own risk. The content on this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay in obtaining medical advice for any medical condition they have, and they should seek the assistance of their healthcare professionals for any such conditions. I take conflicts of interest very seriously. For all of my disclosures and the companies I invest in or advise, please visit my website where I keep an up-to-date and active list of such companies. For a full list of our registered and unregistered trademarks, trade names, and service marks, please review our Terms of Use: https://peterattiamd.com/terms-of-use/

## AI Summary

Here's a comprehensive analysis of the episode:

1. **Executive Summary**:
This episode features Dr. Harold Burstein from Dana Farber Cancer Institute discussing breast cancer diagnosis, treatment, and management. The conversation covers the epidemiology of breast cancer, different types, staging, treatment options, and genetic factors. A key insight is that breast cancer is now the most common cancer diagnosis globally (excluding non-melanoma skin cancer) [00:00:00]. The discussion emphasizes the importance of early detection and multi-disciplinary care approaches.

2. **Key Medical/Scientific Points**:
- Breast cancer has a 1 in 8 (12%) lifetime risk for American women [00:03:18]
- Approximately 275,000 cases annually in US with 38,000 deaths [00:03:18]
- Three main types of breast cancer:
  * ER-positive/HER2-negative (70-75% of cases) [01:16:13]
  * Triple negative (10-15%) [01:17:45]
  * HER2-positive (10-15%) [01:16:08]
- Genetic factors account for 8-10% of cases [01:54:15]

3. **Health Optimization Tips**:

Universal recommendations:
- Regular mammography screening [01:07:58]
- Breast awareness and self-examination [01:11:00]
- Genetic testing if family history present [02:01:40]

Context-specific recommendations:
- More intensive screening for high-risk patients (MRI + mammogram) [01:54:15]
- Consider prophylactic mastectomy for BRCA carriers [01:54:15]

4. **Supplements & Medications**:

Medications mentioned:
- Tamoxifen [01:39:36]
- Aromatase inhibitors [01:39:36]
- Herceptin (trastuzumab) [01:44:55]
- CDK4/6 inhibitors [01:44:55]

5. **Biomarkers & Testing**:
- Mammography with BIRADS scoring [01:12:03]
- Genetic testing for BRCA1/2 and other mutations [01:54:15]
- Hormone receptor status (ER, PR, HER2) [01:16:13]
- Ki67 proliferation marker [01:17:45]

6. **Notable Quotes**:
"Early detection through mammography and effective systemic therapy have each reduced the risk of breast cancer mortality by about half over the past 30-40 years" [01:36:13]

7. **Follow-up Questions**:
1. What is the optimal screening frequency for different risk groups?
2. How do outcomes compare between different treatment centers?
3. What are the latest developments in immunotherapy for breast cancer?
4. How do lifestyle factors influence treatment outcomes?

This analysis captures the main points but there's much more detail in the transcript. Would you like me to expand on any particular aspect?
